BACKGROUND AND PURPOSE: Recent studies demonstrate that an acute diffusion-weighted imaging lesion volume >70 cm(3) predicts poor outcome in patients with stroke. We sought to determine if this threshold could identify patients treated with intra-arterial therapy who would do poorly despite reperfusion. In patients with initial infarcts <70 cm(3), we sought to determine what effect recanalization and time to recanalization had on infarct growth and functional outcome. METHODS: We retrospectively studied 34 consecutive patients with anterior circulation stroke who underwent pretreatment diffusion-weighted imaging and perfusion-weighted imaging and subsequent intra-arterial therapy. Recanalization success and time to recanalization were recorded. Initial diffusion-weighted imaging and mean transit time lesion and final infarct volumes were determined. Patients were stratified based on initial infarct volume, recanalization status, and time to recanalization. Statistical tests were performed to assess differences in clinical and imaging outcomes. Good clinical outcome was defined as a 3-month modified Rankin Scale score <or=2. RESULTS: Among patients with initial infarcts >70 cm(3), all had poor outcomes despite a 50% recanalization rate with mean infarct growth of 114 cm(3). These patients also had the largest mean transit time volumes (P<0.04). Patients with initial infarct volumes <70 cm(3) who recanalized early had the best clinical outcomes (P<0.008) with a 64% rate of modified Rankin Scale score <or=2 and the least infarct growth (P<0.03) with mean growth of 18 cm(3). CONCLUSIONS: This study supports the use of an acute diffusion-weighted imaging lesion volume threshold as an imaging selection criterion for intra-arterial therapy. It also confirms the importance of early reperfusion in selected patients.
BACKGROUND AND PURPOSE: Recent studies demonstrate that an acute diffusion-weighted imaging lesion volume >70 cm(3) predicts poor outcome in patients with stroke. We sought to determine if this threshold could identify patients treated with intra-arterial therapy who would do poorly despite reperfusion. In patients with initial infarcts <70 cm(3), we sought to determine what effect recanalization and time to recanalization had on infarct growth and functional outcome. METHODS: We retrospectively studied 34 consecutive patients with anterior circulation stroke who underwent pretreatment diffusion-weighted imaging and perfusion-weighted imaging and subsequent intra-arterial therapy. Recanalization success and time to recanalization were recorded. Initial diffusion-weighted imaging and mean transit time lesion and final infarct volumes were determined. Patients were stratified based on initial infarct volume, recanalization status, and time to recanalization. Statistical tests were performed to assess differences in clinical and imaging outcomes. Good clinical outcome was defined as a 3-month modified Rankin Scale score <or=2. RESULTS: Among patients with initial infarcts >70 cm(3), all had poor outcomes despite a 50% recanalization rate with mean infarct growth of 114 cm(3). These patients also had the largest mean transit time volumes (P<0.04). Patients with initial infarct volumes <70 cm(3) who recanalized early had the best clinical outcomes (P<0.008) with a 64% rate of modified Rankin Scale score <or=2 and the least infarct growth (P<0.03) with mean growth of 18 cm(3). CONCLUSIONS: This study supports the use of an acute diffusion-weighted imaging lesion volume threshold as an imaging selection criterion for intra-arterial therapy. It also confirms the importance of early reperfusion in selected patients.
Authors: Daniel Sanák; Vladimír Nosál'; David Horák; Andrea Bártková; Kamil Zelenák; Roman Herzig; Jirí Bucil; David Skoloudík; Stanislav Burval; Viera Cisariková; Ivanka Vlachová; Martin Köcher; Jana Zapletalová; Egon Kurca; Petr Kanovský Journal: Neuroradiology Date: 2006-08-29 Impact factor: 2.804
Authors: Osama O Zaidat; Jose I Suarez; Jeffrey L Sunshine; Robert W Tarr; Michael J Alexander; Tony P Smith; David S Enterline; Warren R Selman; Dennis M D Landis Journal: AJNR Am J Neuroradiol Date: 2005-04 Impact factor: 3.825
Authors: Wade S Smith; Gene Sung; Sidney Starkman; Jeffrey L Saver; Chelsea S Kidwell; Y Pierre Gobin; Helmi L Lutsep; Gary M Nesbit; Thomas Grobelny; Marilyn M Rymer; Isaac E Silverman; Randall T Higashida; Ronald F Budzik; Michael P Marks Journal: Stroke Date: 2005-06-16 Impact factor: 7.914
Authors: Götz Thomalla; Christian Schwark; Jan Sobesky; Erich Bluhmki; Jochen B Fiebach; Jens Fiehler; Olivier Zaro Weber; Thomas Kucinski; Eric Juettler; Peter A Ringleb; Hermann Zeumer; Cornelius Weiller; Werner Hacke; Peter D Schellinger; Joachim Röther Journal: Stroke Date: 2006-01-26 Impact factor: 7.914
Authors: M Arnold; K Nedeltchev; L Remonda; U Fischer; C Brekenfeld; B Keserue; G Schroth; H P Mattle Journal: J Neurol Neurosurg Psychiatry Date: 2005-10 Impact factor: 10.154
Authors: Jens Fiehler; Karina Knudsen; Götz Thomalla; Einar Goebell; Michael Rosenkranz; Cornelius Weiller; Joachim Röther; Hermann Zeumer; Thomas Kucinski Journal: AJNR Am J Neuroradiol Date: 2005-05 Impact factor: 3.825
Authors: Marc Ribo; Carlos A Molina; Alex Rovira; Manuel Quintana; Pilar Delgado; Joan Montaner; Elisenda Grivé; Juan F Arenillas; José Alvarez-Sabín Journal: Stroke Date: 2005-02-03 Impact factor: 7.914
Authors: H P Adams; T G Brott; A J Furlan; C R Gomez; J Grotta; C M Helgason; T Kwiatkowski; P D Lyden; J R Marler; J Torner; W Feinberg; M Mayberg; W Thies Journal: Circulation Date: 1996-09-01 Impact factor: 29.690
Authors: N Sillanpää; J T Saarinen; H Rusanen; I Elovaara; P Dastidar; S Soimakallio Journal: AJNR Am J Neuroradiol Date: 2012-06-21 Impact factor: 3.825
Authors: Shervin Kamalian; Andre Kemmling; Roderick C Borgie; Livia T Morais; Seyedmehdi Payabvash; Ana M Franceschi; Shahmir Kamalian; Albert J Yoo; Karen L Furie; Michael H Lev Journal: Stroke Date: 2013-08-29 Impact factor: 7.914
Authors: Mark W Parsons; Soren Christensen; Patrick McElduff; Christopher R Levi; Ken S Butcher; Deidre A De Silva; Martin Ebinger; P Alan Barber; Christopher Bladin; Geoffrey A Donnan; Stephen M Davis Journal: J Cereb Blood Flow Metab Date: 2010-01-20 Impact factor: 6.200
Authors: Olvert A Berkhemer; Shervin Kamalian; R Gilberto González; Charles B L M Majoie; Albert J Yoo Journal: Cardiovasc Eng Technol Date: 2013-12-01 Impact factor: 2.495